Jack Lawler
Director Técnico/Científico/I+D en CHEMOMAB THERAPEUTICS LTD. .
Perfil
Jack Lawler is currently the VP-Global Clinical Development Operations at Chemomab Therapeutics Ltd.
He previously worked as the VP-Clinical Operations & Data Management at Goldfinch Bio, Inc. Mr. Lawler completed his undergraduate degree at Rosemont College.
Cargos activos de Jack Lawler
Empresas | Cargo | Inicio |
---|---|---|
CHEMOMAB THERAPEUTICS LTD. | Director Técnico/Científico/I+D | 04/01/2022 |
Antiguos cargos conocidos de Jack Lawler.
Empresas | Cargo | Fin |
---|---|---|
Goldfinch Bio, Inc.
Goldfinch Bio, Inc. Pharmaceuticals: MajorHealth Technology Goldfinch Bio, Inc. operates as a biotechnology company. It focuses on discovering and developing precision therapies for patients with kidney disease. The firm develops and manufactures medicines. The company was founded by Joseph Vincent Bonventre, Anna Greka, Fridhelm Hildebrandt, Daniel MacArthur, Stefan Somlo and Peter Mundel in December 2016 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
Formación de Jack Lawler.
Rosemont College | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
CHEMOMAB THERAPEUTICS LTD. | Health Technology |
Empresas privadas | 1 |
---|---|
Goldfinch Bio, Inc.
Goldfinch Bio, Inc. Pharmaceuticals: MajorHealth Technology Goldfinch Bio, Inc. operates as a biotechnology company. It focuses on discovering and developing precision therapies for patients with kidney disease. The firm develops and manufactures medicines. The company was founded by Joseph Vincent Bonventre, Anna Greka, Fridhelm Hildebrandt, Daniel MacArthur, Stefan Somlo and Peter Mundel in December 2016 and is headquartered in Cambridge, MA. | Health Technology |
- Bolsa de valores
- Insiders
- Jack Lawler